Inventor
GIRARDET JEAN-LUC
US35 patents
⚠️ This page may combine multiple inventors who share the name “GIRARDET JEAN-LUC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARDEA BIOSCIENCES INC
10 patentsUS8003681B2Aug 23, 2011
2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
ARDEA BIOSCIENCES INC31 citations96
US7435752B2Oct 14, 2008
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benozioc acids as HIV reverse transcriptase inhibitors
ARDEA BIOSCIENCES INC50 citations95
US7683087B2Mar 23, 2010
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl] -p-amino benzoic acids as HIV reverse transcriptase inhibitors
ARDEA BIOSCIENCES INC34 citations92
US8357713B2Jan 22, 2013
Compounds and compositions and methods of use
ARDEA BIOSCIENCES INC9 citations83
US8372807B2Feb 12, 2013
Methods of modulating uric acid levels
ARDEA BIOSCIENCES INC8 citations81
US7595324B2Sep 29, 2009
Substituted thieno[3,2-D]pyrimidines as HIV inhibitors
ARDEA BIOSCIENCES INC7 citations72
US8344012B2Jan 1, 2013
Compounds, compositions and methods of using same for modulating uric acid levels
ARDEA BIOSCIENCES INC3 citations62
US10183012B2Jan 22, 2019
Compounds and compositions and methods of use
ARDEA BIOSCIENCES INC0 citations51
US8354532B2Jan 15, 2013
Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
ARDEA BIOSCIENCES INC0 citations51
US9956205B2May 1, 2018
Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
ARDEA BIOSCIENCES INC1 citations50
GIRARDET JEAN-LUC
8 patentsUS8106205B2Jan 31, 2012
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]p-amino benzoic acids as HIV reverse transcriptase inhibitors
GIRARDET JEAN-LUC13 citations92
US8552043B2Oct 8, 2013
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitors
GIRARDET JEAN-LUC5 citations83
US8252828B2Aug 28, 2012
S-triazolyl α-mercapto acetanilides as inhibitors of HIV reverse transcriptase
GIRARDET JEAN-LUC7 citations83
US8481581B2Jul 9, 2013
S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
GIRARDET JEAN-LUC3 citations62
US8227601B2Jul 24, 2012
Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of HIV
GIRARDET JEAN-LUC4 citations61
US8946273B2Feb 3, 2015
S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptase
GIRARDET JEAN-LUC3 citations60
US8324223B2Dec 4, 2012
Substituted thieno [2,3-d] pyrimidines as HIV inhibitors
GIRARDET JEAN-LUC0 citations51
US8211898B2Jul 3, 2012
Substituted thieno[3,2-d]pyrimidines as HIV inhibitors
GIRARDET JEAN-LUC0 citations51
GUNIC ESMIR
4 patentsUS8173690B2May 8, 2012
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR21 citations90
US8193234B2Jun 5, 2012
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR13 citations83
US8633232B2Jan 21, 2014
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR7 citations82
US8242154B2Aug 14, 2012
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR11 citations82
VALEANT RES & DEV
3 patentsUS7081449B2Jul 25, 2006
Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides
VALEANT RES & DEV72 citations97
US7247621B2Jul 24, 2007
Antiviral phosphonate compounds and methods therefor
VALEANT RES & DEV39 citations92
US7371857B2May 13, 2008
Synthesis for hydroxyalkylated heterocyclic bases
VALEANT RES & DEV4 citations61